Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Kanagawa, Japan.
Department of Rehabilitation, Sagami Circulatory Organ Clinic, Kanagawa, Japan.
Nephrol Dial Transplant. 2023 Nov 30;38(12):2704-2712. doi: 10.1093/ndt/gfad109.
Patients undergoing hemodialysis (HD) have difficulty increasing their gait speed in daily life. The extent of the increase from the usual gait speed (UGS) to the maximum gait speed (MGS) is considered the reserved gait capacity (RGC). Little is known regarding the implications of RGC. This study aimed to investigate the association between RGC and all-cause mortality in patients undergoing HD.
In this retrospective study, we assessed the usual and maximum 10-m walking speed of outpatients who underwent HD between October 2002 and August 2021. RGC was defined as the ratio of MGS to UGS. Patients were divided into three groups according to the tertiles of RGC (low, moderate and high). A Cox proportional hazards regression model was used to examine the association between RGC and all-cause mortality.
Of the 496 (median age 66.0 years; men 59%) participants, 186 patients died during the follow-up (incident ratio of 62.0 per 1000 person-years). The patients with moderate [hazard ratio (HR) 0.66, 95% confidence interval (CI) 0.46-0.94] and high (HR 0.44, 95% CI 0.30-0.65) RGC had a lower risk of mortality than the low RGC group. Furthermore, even when restricted to a population with only UGS <1.0 m/s, the group with high RGC still had a lower risk of mortality than those with low RGC (HR 0.55, 95% CI 0.33-0.94).
Lower RGC was independently associated with an increased risk of all-cause mortality among patients on HD; high RGC had a survival advantage even with a slow UGS.
接受血液透析(HD)的患者在日常生活中难以提高他们的步行速度。从通常的步行速度(UGS)到最大步行速度(MGS)的增加程度被认为是保留的步行能力(RGC)。关于 RGC 的影响知之甚少。本研究旨在探讨 RGC 与接受 HD 的患者全因死亡率之间的关系。
在这项回顾性研究中,我们评估了 2002 年 10 月至 2021 年 8 月期间接受 HD 的门诊患者的通常和最大 10 米步行速度。RGC 定义为 MGS 与 UGS 的比值。根据 RGC 的三分位数(低、中、高),将患者分为三组。使用 Cox 比例风险回归模型来检查 RGC 与全因死亡率之间的关系。
在 496 名(中位年龄 66.0 岁;男性 59%)参与者中,有 186 名患者在随访期间死亡(发生率为每 1000 人年 62.0 人)。RGC 中度(危险比[HR]0.66,95%置信区间[CI]0.46-0.94)和高度(HR 0.44,95% CI 0.30-0.65)的患者死亡风险低于低 RGC 组。此外,即使将研究对象仅限于 UGS<1.0m/s 的人群,RGC 高的组死亡风险仍低于 RGC 低的组(HR 0.55,95% CI 0.33-0.94)。
在接受 HD 的患者中,较低的 RGC 与全因死亡率的增加独立相关;即使 UGS 较慢,RGC 高也具有生存优势。